These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 4422166)

  • 1. 'Hormonogen' analogues of lysine vasopressin: rat pressor and antidiuretic activities.
    Kyncl J; Rezábek K; Kasafírek E; Pliska V; Rudinger J
    Eur J Pharmacol; 1974 Oct; 28(2):294-301. PubMed ID: 4422166
    [No Abstract]   [Full Text] [Related]  

  • 2. Solid phase synthesis and some pharmacological properties of 8-D-homoarginine-vasopressin and 1-deamino-8-D-homoarginine-vasopressin.
    Gunnar E; Lindeberg G; Melin P; Larsson LE
    Int J Pept Protein Res; 1976; 8(2):193-8. PubMed ID: 1270191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of rat kidney adenylate cyclase by vasopressin analogues: lack of correlation with antidiuretic activity.
    Barth T; Rajerison MR; Roy C; Jard S
    Mol Cell Endocrinol; 1975 Jan; 2(2):81-90. PubMed ID: 1149917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of O-alkylated lysine-vasopressins, inhibitors of the antidiuretic response to lysine-vasopressin.
    Larsson LE; Lindeberg G; Melin P; Pliska V
    J Med Chem; 1978 Apr; 21(4):352-6. PubMed ID: 650663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solid phase synthesis and some pharmacological properties of 8-D-homolysine-vasopressin and 1-deamino-8-D-homolysine-vasopressin.
    Gunnar E; Lindeberg G
    Int J Pept Protein Res; 1975; 7(5):395-401. PubMed ID: 1184288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antidiuretic agonism and antagonism of some O-alkylated analogues of vasopressin containing 2-O-alkylated tyrosine.
    Melin P; Lundin S; Vilhardt H; Lindeberg G; Larsson LE; Pliska V
    Eur J Pharmacol; 1980 Oct; 67(2-3):173-7. PubMed ID: 7461030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regional and systemic haemodynamic effects of some vasopressins: structural features of the hormone which prolong activity.
    Cort JH; Albrecht I; Nováková J; Mulder JL; Jost K
    Eur J Clin Invest; 1975 Apr; 5(2):165-75. PubMed ID: 168085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasopressin analog with extraordinarily high antidiuretic potency: a study of conformation and activity.
    Smith CW; Walter R
    Science; 1978 Jan; 199(4326):297-9. PubMed ID: 619455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solid phase synthesis and some hormonal activities of 1-deamino-4-L-valine-8-D-homolysine-and 1-deamino-4-L-valine-8-D-homoarginine-vasopressin.
    Lindeberg G; Karlsson SM; Melin P
    Int J Pept Protein Res; 1977; 10(3):240-4. PubMed ID: 914427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the substitution of photoreactive groups in positions 4 and 8 of vasopressin.
    Buku A; Yamin N; Gazis D
    Int J Pept Protein Res; 1989 Jul; 34(1):28-32. PubMed ID: 2507457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 4-Proline and 4-hydroxyproline analogs of arginine vasopressin: role of the proline substitution in the two beta-turns of vasopressin.
    Buku A; Yamin N; Gazis D
    Experientia; 1987 Dec; 43(11-12):1218-9. PubMed ID: 3691742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antidiuretic and pressor actions of vasopressin in age-dependent DOCA-salt hypertension.
    Zicha J; Kunes J; Lébl M; Pohlová I; Slaninová J; Jelínek J
    Am J Physiol; 1989 Jan; 256(1 Pt 2):R138-45. PubMed ID: 2912206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex differences in the cardiovascular and renal actions of vasopressin in conscious rats.
    Wang YX; Crofton JT; Share L
    Am J Physiol; 1997 Jan; 272(1 Pt 2):R370-6. PubMed ID: 9039031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the vasoconstrictor and antidiuretic activities of vasopressin in inhibition of renin secretion in conscious dogs.
    Schwartz J; Reid IA
    Am J Physiol; 1986 Jan; 250(1 Pt 2):F92-6. PubMed ID: 3510566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and some pharmacological properties of (3-beta-(2-thienyl)-L-alanine)-8-lysine-vasopressin.
    Smith CW; Ferger MF; Chan WY
    J Med Chem; 1975 Aug; 18(8):822-5. PubMed ID: 1171984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of antidiuretic activity in the rat for structural analogues of the neurohypophysial hormones.
    Pliska V; Rychlík I
    Acta Endocrinol (Copenh); 1967 Jan; 54(1):129-40. PubMed ID: 6071208
    [No Abstract]   [Full Text] [Related]  

  • 17. [Antidiuretic and pressor effects of arginine-8-vasopressin, lysine-8-vasopressin, phenylalanine-2-lysine-8-vasopressin in man].
    GUHL U
    Schweiz Med Wochenschr; 1961 Jul; 91():798-804. PubMed ID: 13709554
    [No Abstract]   [Full Text] [Related]  

  • 18. Antidiuretic activity and release of factor VIII by vasopressin analogues.
    Vilhardt H; Barth T; Melin P; Aurell CJ
    Eur J Pharmacol; 1993 Mar; 232(2-3):223-6. PubMed ID: 8467859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solid-phase synthesis and pressor potency of (1-deamino-9-ethylenediamine)-lysine-vasopressin.
    Glass JD; Du Vigneaud V
    J Med Chem; 1973 Feb; 16(2):160-1. PubMed ID: 4683112
    [No Abstract]   [Full Text] [Related]  

  • 20. The dose-response relation of the antidiuretic and vasopressor activities of 4-asparagine-8-lysine-vasopressin.
    Pliska V; Krejcí I
    Arch Int Pharmacodyn Ther; 1966 Jun; 161(2):289-97. PubMed ID: 5926871
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.